Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CTR20231096Phase 3Completed
A Phase 3 trial of mitoxantrone hydrochloride in gastric adenocarcinoma, sponsored by Shenyang Pharmaceutical University. Started Apr 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on CTR20231096.